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Abstract
Melioidosis is caused by Burkholderia pseudomallei, a Gram-negative bacillus, primarily found in soils in Southeast Asia and
northern Australia. A recent case of melioidosis in non-endemic Arizona was determined to be the result of locally acquired
infection, as the patient had no travel history to endemic regions and no previous history of disease. Diagnosis of the case
was confirmed through multiple microbiologic and molecular techniques. To enhance the epidemiological analysis, we
conducted several molecular genotyping procedures, including multi-locus sequence typing, SNP-profiling, and whole
genome sequence typing. Each technique has different molecular epidemiologic advantages, all of which provided
evidence that the infecting strain was most similar to those found in Southeast Asia, possibly originating in, or around,
Malaysia. Advancements in new typing technologies provide genotyping resolution not previously available to public
health investigators, allowing for more accurate source identification.
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Introduction
An apparent autochthonous case of melioidosis was identified in
rural southeastern AZ, U.S., in October 2008 [1]. The patient, with
no prior travel history to endemic regions, was confirmed as being
infected with Burkholderia pseudomallei, the etiological agent of
melioidosis. As no endemic cases of melioidosis have been identified
in the United States previous to this case, it is likely that a
contaminated commodity was the source of this local infection.
Background
B. pseudomallei, a Gram-negative bacillus, is a soil saprophyte
capable of surviving harsh environmental conditions. Melioidosis
is a serious disease caused by infection with B. pseudomallei via
inoculation, aspiration or ingestion, resulting in high mortality
rates [2]. It is considered a Biosafety Level 3 organism due to risks
of aerosolization and severe disease and it is on the U.S. Federal
list of Select Agents [3]. It is found in soils throughout Southeast
Asia and northern Australia, with sporadic populations and
infections found in many parts of the world, except North
America and Europe [4]. B. pseudomallei is closely related to a
number of other Burkholderia species and suspect cases in non-
endemic regions need to be genetically confirmed to rule out
misidentification of the pathogenic agent. Here we describe a
molecular investigation of the first reported [1] instance of
apparent non-human-to-human autochthonous transmission of
B. pseudomallei in the United States.
Case Information
In October of 2008, a 32-year-old diabetic male was admitted to a
rural Arizona hospital with severe knee pain and an initial diagnosis
of E. coli septicemia [1]. The patient did not improve after eight days
of antimicrobial therapy and was transferred to a large acute care
hospital. Blood cultures at the second hospital grew suspect B.
pseudomallei, via automated biochemical analysis (Vitek, bioMerieux,
France). Subsequent sputum and knee aspirate samples also grew
apparent B. pseudomallei cultures. These results were confirmed at the
Arizona State Public Health Laboratory (Phoenix, AZ), through the
use of the Laboratory Response Network real-time PCR protocols for
B. pseudomallei [5], and subsequently at the U.S. Centers for Disease
Control and Prevention (CDC) (Atlanta, GA). As the patient had no
travel or other exposure history and due to the lack of endemic
transmission of B. pseudomallei in the United States, advanced
molecular studies were conducted to assist with the investigation.
Methods
Samples
Only one original culture isolate from the patient was available
for molecular analysis. No additional isolates were identified
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during the course of the epidemiologic investigation involving
patient contacts, pets, home-site soil and imported plants. The case
isolate was provided by the Arizona State Health Laboratory and
was handled, extracted and stored in the select agent certified
BSL3 laboratory at Northern Arizona University (Flagstaff, AZ).
The isolate was streaked on Ashdown’s agar and incubated at
37uC for 48 hr. DNA was extracted from bacterial growth using
Wizard genomic DNA purification kit (Promega, USA), using
manufacturer’s protocol. Sterility tests were performed on the
DNA samples prior to removal from bio-safety containment.
PCR Profiling
PCR assays targeting the genetic loci listed in Table 1 were
performed [6–10] (see Table S1 for specific assay primer/probe
sequences). These assays include species detection for B. pseudomallei
(TTS1, bimABp, BurkDiff-Bp) [6,9,10]; B. mallei, the etiologic agent
of glanders and also known as a recent clone of B. pseudomallei
(bimABm, BurkDiff-Bm) [9,10]; and B. thailandensis, a common soil
species that rarely causes human infection (cheB) [7]. Additionally,
we targeted known virulence (wcbG, bpaA, fhaB_1-3) and metabolic
(BPSS0654) genes [8]. Lastly, we also included real-time PCR assays
to a pair of genetic targets that distinguishes the Southeast Asian B.
pseudomallei (YLF) from Australian (BTFC) populations [7]. Real-
time PCR was carried out in a 384-well plate in 10 uL reactions
containing 900 nM of forward and reverse primers, 250 nM of
probe for single-assay reactions or 200 nM of each probe for duplex
reactions, 16 Applied Biosystems Universal Mastermix (Life
Technologies, Carlsbad, CA), and 0.5 ng template. 16 Applied
Biosystems Genotyping Mastermix (Life Technologies) was used in
place of Universal Mastermix for the BurkDiff assay [10]. Thermal
cycling and endpoint analysis was performed on an AB 7900HT
sequence detection system (Life Technologies) using the following
conditions: 50uC for 2 min, 95uC for 10 min, and 40 cycles of 95uC
for 15 s and 58uC for 1 min. Positive controls for each assay are
listed in Table S2 and negative controls consisted of several near
neighbor (i.e., strains of non-B. psuedomallei Burkholderia species) and
non-related bacterial strains along with ‘‘no template’’ controls.
MLST Genotyping
We conducted multi-locus sequence typing (MLST) for
standardized genotyping, as previously described [11]. The
identified allele profile was assigned a sequence type (ST) based
on the naming conventions described in the MLST database [12].
We then used Structure [13] to conduct population genetic analyses
comparing identified sequence types to the MLST database, to
better understand the likelihood of broad geographic origination.
Whole Genome Sequencing
To further detail the genomic features of the case strain and to
compare to B. pseudomallei genome sequences, we conducted whole
genome sequence analysis, using next generation sequence
technology. DNA libraries were prepared for sequencing on the
Illumina Genome Analyzer II, using a protocol provided by
Illumina (San Diego, CA, USA). About 2 mg of DNA was sheared
with the SonicMANTM (Part # SCM1000-3, Matrical Bioscience,
Spokane, WA) to an average size of 600 base pairs with the
following parameters: Sonication - 10 sec; Power -100%. The
remainder of the preparation followed the Illumina protocol
(‘‘Preparing Samples for Multiplexed Paired-End Sequencing’’,
Catalog #PE-930-1002, Part #1005361). The library was
quantified using the Bioanalyzer per the Illumina protocol. The
paired end library was sequenced on the Illumina GAII platform
to a length of 50 base pairs per read.
The sequenced reads were aligned to Burkholderia pseudomallei
K96243 chromosomes 1 and 2 (Genbank ID’s BX571965 and
BX571966, respectively) using Burrows-Wheeler Aligner [14]. Inser-
tions and deletions were removed as well as alignments that mapped
to multiple locations. SolSNP (http://sourceforge.net/projects/
solsnp/) was used to identify SNPs from the alignment file. SNPs
that were not present in 90% of the base calls at each position and did
not meet a minimum coverage of 106 were removed. Publically
available genomes were aligned against K96243 using MUMmer
3.22 [15]. SNPs were identified from the alignments using a custom
script, allowing for placement in a well-established phylogeny [16].
SNPs within duplicated regions were identified with MUMmer 3.22
and removed from the phylogenetic analysis. Alleles lacking coverage
were removed as well. The maximum parsimony algorithm in
MEGA5 [17], with the average pathway method to determine
branch lengths [18], was used for phylogenetic analysis. Where
shown, bootstrap analysis was performed with 1000 generations.
Results
PCR-Profiling
As listed in Table 1, the detection assays (TTS1, bimABp,
BurkDiff-Bp) were positive for B. pseudomallei, and the detection
assays for B. mallei (bimABm, BurkDiff-Bm) and B. thailandensis (cheB)
were negative. The YLF+ versus BTFC- results grouped the
patient isolate with Southeast Asia populations. The profile of
virulence gene assay results (fhaB_1+, B_2+ and B_3 +, wcbG+,
bpaA2) is rare, seen only previously in limited environmental
isolates and clinical samples in Southeast Asia [8].
MLST
When compared to the global MLST database [12], the case
isolate alleles were identical to a single previously typed isolate
from a patient presenting with severe melioidosis in Australia
(ST426). Further epidemiological follow-up determined that the
Australian patient was infected in Malaysia. Population genetic
analyses placed this isolate with 85% likelihood in the Southeast
Asian population (Figure 1).
Whole Genome Sequencing and Typing (WGST)
The sequence run generated 29,517,572 50-base pair paired-
end reads (1,476 Mb). The average read length was 44 base pairs.
Author Summary
Melioidosis is a bacterial disease caused by percutaneous
inoculation, aspiration or ingestion of the soil bacteria
Burkholderia pseudomallei. Melioidosis is primarily found in
Southeast Asia and Northern Australia, and, to a lesser
degree, nearby regions. A recent case of melioidosis in
Southwestern United States (Southern Arizona) prompted
a detailed epidemiological and molecular investigation to
discover the source of infection. The authors describe the
use of multiple genomic analysis tools to aid in this
investigation. The results of these analyses uniformly
identified Southeast Asia as the source of the strain that
infected the patient, however the epidemiological inves-
tigation had determined the patient had no international
travel or known exposures to Southeast Asian products.
New cutting edge technologies, such as next generation
sequencing, are quickly being adapted into epidemiologic
investigations, particularly for cases and outbreaks of
unknown origin, although older, mature technologies with
larger existing databases will still be needed for appropri-
ate comparative analyses.
Molecular Analysis of Non-Endemic Melioidosis Case
www.plosntds.org 2 October 2011 | Volume 5 | Issue 10 | e1347
Reads mapped to 88.6% of the K92643 with a minimum of 106
coverage at each base included in the analysis. Using B. pseudomallei
K96243 strain as the reference, we identified 54,135 orthologous
SNP loci, including 31,202 parsimony informative SNPs. When
comparing the shared SNP states of the case isolate to the publically
available 32 B. pseudomallei and B. mallei whole genome sequences, a
maximum parsimony phylogenetic analysis grouped the case
genome with Southeast Asian strains (Figure 2). Interestingly, the
case isolate along with a Thai strain (Bp576) are on the branch that
contains the B. mallei clone. The B. mallei clone was previously shown
to belong to the Southeast Asian clade [16].
Discussion
This report describes molecular investigations into the first case of
non-human-to-human locally acquired melioidosis infection in the
United States; a possible sexually transmitted U.S. autochthonous
case associated with a returning Viet Nam veteran in 1971 has been
previously described [19]. In this case, without a clear mechanism of
transmission, an in-depth molecular analysis was necessary to help
understand the possible nature of the exposure and the isolate. Here
we used standard and novel tools to confirm the identification of B.
pseudomallei and further characterize the isolate as most likely
originating from materials coming from Southeast Asia, possibly in
or around Malaysia. Despite on-site epidemiological investigations
[1], no physical or historical evidence was discovered to link the
patient to this region of the world.
As B. pseudomallei is classified as a Select Agent [3], identification
of even an individual case of melioidosis in non-endemic regions
requires initial law enforcement notification and rapid epidemi-
ological and forensic analysis to rule out suspect terrorism. The
real-time PCR assays used in this investigation provided public
health and safety officials with initial information regarding
potential source location of the etiological agent – the presence
of all three fhaB virulence genes and the positive YLF result are
typically only seen with Southeast Asian isolates [8]. Ensuing
genotyping methodologies confirmed this finding. These initial
data also were useful in focusing the on-site epidemiological
investigation for possible sources of fomites and/or products
associated with the exposure.
As a comparative or source isolate was not identified during the
investigation, appropriate genotyping tools were limited. Addi-
Table 1. Real-time PCR assay panel and results used to profile case isolate.
Genomic target Result Specificity Target info
TTS1 Pos. B.ps. Type III secretion gene cluster [6]
YLF Pos. SEA isolates of B.ps. Yersinia-like fimbrial gene cluster; mutually exclusive of BTFC; mostly found in B.ps. from Thailand [7]
BTFC Neg. Australian isolates of B.ps. B. thailandensis-like flagella & chemotaxis gene cluster; mutually exclusive of YLF; mostly found in B.
ps. from Australia [7]
cheB Neg. B. thailandensis B. thailandensis homolog of BTFC [7]
wcbG Pos. B.ps. virulence gene A gene in the wcb capsule biosynthesis operon; more prevalent in clinical isolates than
environmental isolates of B. ps. (A. Tuanyok, unpublished data)
fhaB_1 Pos. B.ps. virulence gene Filamentous hemagglutinin (adhesin; a virulence molecule produced by intracellular bacteria). B.ps.
fhaB genes vary in sequence and copy number among strains and may infer geographic origin. [8]
fhaB_2 Pos. B.ps. virulence gene
fhaB_3 Pos. B.ps. virulence gene
bimABm Neg. Most B.m., some B.ps. Burkholderia intracellular motility A protein (a virulence factor) – B. mallei dominant [9]
bimABp Neg. Most B.ps. Burkholderia intracellular motility A protein (a virulence factor) – B. pseudomallei dominant [9]
bpaA Neg. B.ps. virulence gene Virulence gene located on a genomic island [8]
BPSS0654 Pos. B.ps. metabolic gene Common metabolic gene on genomic islands [8]
BurkDiff B.ps. Pos.
B.m. Neg.
B.m. and B.ps. Single nucleotide polymorphism differentiating B.m. from B.ps. Flanking region is unique to these
two species. (10)
(B.ps.= B. pseudomallei; B.m.= B. mallei; Pos. = Positive; Neg. = Negative; SEA = Southeast Asia).
doi:10.1371/journal.pntd.0001347.t001
Figure 1. Population assignment of case isolate based on MLST sequence type. An estimated population assignment of case isolate
(ST426) compared to 640 other MLST sequence types was developed using Structure [13]. Each thin vertical line represents one sequence type (ST)
and is divided into 2 portions that represent the likelihood of assignment into each population. STs are sorted by likelihood of assignment into two
populations. STs from strains collected in Australia dominate the left hand population and STs from strains collected in Southeast Asia dominate the
right hand population. The case isolate was placed in the second population in 85% of 100,000 iterations.
doi:10.1371/journal.pntd.0001347.g001
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tionally, given the highly recombinagenic nature of B. pseudomallei
[20], the connection between genotypes (isolates linked by
apparent genetic similarities) and phylotypes (isolates linked by
evolutionary relationships) is limited at best. Multiple genotyping
systems for B. pseudomallei, however, have been published,
including pulsed-field gel electrophoresis, randomly amplified
polymorphic DNA [21], multi-locus VNTR analysis (MLVA) [22],
PCR-based genotyping [7], multi-locus sequence typing (MLST)
[12], and more recently, orthologous SNP analysis (WGST) [16].
We employed the latter three systems, or variations thereof, for
this investigation to achieve the highest molecular epidemiologic
confidence possible for this unusual melioidosis case. These
analyses have different species and strain resolution powers and
varying support from genetic databases. The greatest resolution
can be achieved through WGST (using thousands of loci), but, due
to the just-recent application of this technology to molecular
epidemiology, this system has limited comparative strain databas-
es. Other methodologies have more limited resolving capacity (e.g.,
MLST), but are complemented with extensive strain databases.
MLVA, although known to have high resolving power, was not
used in this investigation, as it is appropriate for comparison of
only known closely related isolates [23].
Assigning isolates to specific MLST sequence types allows for
the inference of epidemiological linkage between identical
genotypes, but has limited use in determining relationships among
sequence types [16], restricting its usefulness for phylogeographic
analysis, and in turn, molecular epidemiology. Nevertheless,
MLST has proved very discriminatory when comparing large B.
pseudomallei isolate sets from across melioidosis-endemic northern
Australia, with no ST yet found to be common to both the
Northern Territory and Queensland [24]. Furthermore, when
correct attribution of location of origin of B. pseudomallei strains is
Figure 2. Maximum parsimony phylogenetic comparison of case isolate sequence to all available B. pseudomallei sequences. The
case isolate whole genome sequence (WGS) was compared to 22 B. pseudomallei and 10 B. mallei sequences, using 54,135 shared SNPs (including
31,202 parsimony informative SNPs). MEGA5 [17] was used to conduct maximum parsimony analysis of all SNP loci common to the genome
sequences. The percentages of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) are shown next
to the branches. The tree is drawn to scale, with branch lengths calculated using the average pathway method [18] and are in the units of the number
of changes over the whole sequence.
doi:10.1371/journal.pntd.0001347.g002
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confirmed, no MLST ST has to date been found to be common to
both Australia and Southeast Asia [25], allowing for inference of
larger scale geographic origin based on sequence type [16]. The
exact MLST match of the case with only one other isolate in the
global MLST database (ST426 – isolate #MSHR158 from case
exposed in Malaysia) and the MLST population genetic analysis
provides substantial evidence of the originating location.
Due to the limitations of MLST in determining relationships
among sequence types, we were restricted in our ability to further
refine our estimates of geographic origin using this technique. We
therefore explored more loci-intensive genotyping systems, micro-
array SNP screening and WGST, using SNPs derived from whole
genome analyses. SNP-based genotyping is known to be highly
accurate in terms of defining population subgroups and isolate
relationships, especially in clonal organisms [26]. SNPs are
considered to be more phylogenetically informative than other
molecular markers (e.g., VNTRs) due to their typically biallelic
nature, slow mutation rates and genome-wide distribution [27].
However, the use of SNPs for phylogenetic analysis in B. pseudomallei
is not straightforward due to character state conflicts arising from
genetic recombination via lateral gene transfer. No significant
consensus was identified from phylogenetic analysis of a moderate
number of orthologous SNP loci (n,500), screened via microarray,
due to this described homoplasy (See Text S1 and Figure S1).
However, the use of large SNP data sets has been shown to mitigate
this challenge [16,28]. WGST was used to compare the case isolate
genome to all existing whole genome sequences. The strength of this
analysis is in the comparison of all potential differences and
similarities in the genome (in this case, nearly 30,000 orthologous
SNPs), thereby establishing evolutionary lineages and providing the
best evidence of phylogenetic relationships. The limitation of this
analysis is the relatively small number of whole genomes available
for comparative analysis (n= 23). This limited number of whole
genomes prevents more fine-scale phylogeographic inference,
primarily due to likely branch collapse caused by selection bias
[26]. In other words, a bias is introduced by the selection or
availability of strains that may not represent the true phylogenetic
diversity of an organism. The result is collapsed secondary branches
in the structure that lead to strains that have not been sequenced yet
[26]. As with the other genotyping tools used in this study, WGST
phylogenetic analysis placed the clinical isolate among isolates from
Southeast Asia. The association of the strain with the pre-B. mallei
branch requires further analysis, however this finding is not
surprising given previous discovery that the B. mallei species is a
clone found in the Southeast Asian B. pseudomallei population [16].
It is possible that this patient had a low dose exposure to B.
pseudomallei, as has been described previously [29,30], limiting the
success of the subsequent epidemiological investigations in finding
the source, whether in the environment or contaminated products.
Future epidemiological studies may have better success in
identifying environmental sources with continued improvement
of technologies for sensitive detection of limited or remnant DNA.
Next generation and third generation sequencing technologies
can be expected to be more widely used in epidemiological
investigations as costs decrease and speed, coverage and accuracy
increase [28,31–33]. However, other molecular methods are
needed to bridge the gap between vast amounts of data gathered
from a small number of strains and fewer data from a large number
of isolates. Indeed, a comparison of clinical strains to a large
database of molecular data from a diverse and comprehensive strain
collection is needed for precise attribution. For B. pseudomallei,
recombination among strains complicates attribution efforts
requiring large numbers of loci for accurate determination of strain
relatedness. Our use of the large B. pseudomallei MLST database,
PCR profiling, and WGST all provide evidence with complemen-
tary strengths and weaknesses that point to a Southeast Asian
ancestry for the clinical isolate. Future investigations can and should
use next generation sequencing data for both WGST and MLST
(which can be extracted from the assembled/aligned sequence
reads), as the cost of reagents is now around $100 (US) per isolate
(for similar analyses described here). Additionally, the availability of
whole genome data will allow for additional comparative genomics
studies that may provide additional clinical, public health,
biodefense and basic science benefit. As next generation instruments
and bioinformatic tools continue to become more user-focused and
routine, sequence databases are becoming more robust and use of
whole genome data will feasibly, and necessarily, become a standard
for molecular epidemiology. This will provide improved ability to
quickly link isolates together, understand phylogeographic relation-
ships, and determine outbreak source.
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Figure S1 B. pseudomallei microarray SNP phylogeny.
A phylogeny (neighbor joining tree) derived from 151 SNPs from
108 available B. pseudomallei, B. mallei, and B. thailandensis whole
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is drawn to scale with branch lengths calculated using the average
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over the whole sequence. Due to high levels of recombination and
subsequent homoplasy (SNPs accruing in evolutionarily indepen-
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Analysis includes approximately 20 replicates for precision control.
Map generated from maps.google.com.
(JPG)
Table S1 Primer and probe design and amplicon size
for PCR assays.
(DOC)
Table S2 Positive control strains by assay.
(DOC)
Text S1 Supplemental methods and results for SNP
microarray analysis.
(DOC)
Acknowledgments
The authors wish to acknowledge Ken Komatsu, Jordan Buchhagen,
Richard Lester, Jay Gee, Alex Hoffmaster, Mindy Glass, and Allen Cheng
for their support on this investigation and data analysis.
Author Contributions
Conceived and designed the experiments: DME JAS TP DMW MM BJC
PK AT. Performed the experiments: JB JAS JG HMH JD JG LBP TC.
Analyzed the data: DME JB JAS TP LBP JG SMB-S MM BJC PK AT.
Contributed reagents/materials/analysis tools: DME TS RS VW CL DDB
MM AT. Wrote the paper: DME JAS TP TS BJC PK AT. Assisted with
on site field investigation and sample collection: JB JG TP TS AT.
References
1. Stewart T, Engelthaler DM, Blaney D, Tuanyok A, Wangsness E, et al. (2011)
Epidemiology and Investigation of Melioidosis in Southern Arizona. Emerg
Infect Dis 17(7): 1286–88.
2. Peacock SJ (2006) Melioidosis. Curr Opin Infect Dis 19: 421–428.
3. Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM (2002) Public health
assessment of potential biological terrorism agents. Emerg Infect Dis 8: 225–230.
Molecular Analysis of Non-Endemic Melioidosis Case
www.plosntds.org 5 October 2011 | Volume 5 | Issue 10 | e1347
4. Cheng AC, Currie BJ (2005) Melioidosis: epidemiology, pathophysiology, and
management. Clin Microbiol Rev 18: 383–416.
5. Centers for Disease Control and Prevention. 11 March 2005, posting date.
Laboratory Preparedness for Emergencies. The Laboratory Response Network:
Partners in Preparedness. http://www.bt.cdc.gov/lrn/. Accessed 2010 March 8.
6. Novak RT, Glass MB, Gee JE, Gal D, Mayo MJ, et al. (2006) Development and
Evaluation of a Real-Time PCR Assay Targeting the Type III Secretion System
of Burkholderia pseudomallei. J Clin Microbiol 44(1): 85–90.
7. Tuanyok A, Auerbach RK, Brettin TS, Bruce DC, Munk AC, et al. (2007) A
horizontal gene transfer event defines two distinct groups within Burkholderia
pseudomallei that have dissimilar geographic distributions. J Bacteriol 189(24):
9044–9.
8. Tuanyok A, Leadem BR, Auerbach RK, Beckstrom-Sternberg SM, Beckstrom-
Sternberg JS, et al. (2008) Genomic islands from five strains of Burkholderia
pseudomallei. BMC Genomics 27(9): 566.
9. Ulrich MP, Norwood DA, Christensen DR, Ulrich RL (2006) Using real-time
PCR to specifically detect Burkholderia mallei. J Med Microbiol 55(Pt 5): 551–9.
10. Bowers JR, Engelthaler DM, Ginther JL, Pearson T, Peacock SJ (2010)
BurkDiff: A Real-Time PCR Allelic Discrimination Assay for Burkholderia
pseudomallei and B. mallei. PLoS One 5(11): e15413.
11. Godoy D, Randle G, Simpson AJ, Aanensen DM, Pitt TL (2003) Multilocus
sequence typing and evolutionary relationships among the causative agents of
melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei.
J Clin Microbiol 41: 2068–2079.
12. Multi Locus Sequence Typing – Burkholderia pseudomallei MLST [Internet].
London: Imperial College, [cited 2011 March 7]. http://bpseudomallei.mlst.
net/.
13. Pritchard JK, Stephens M, Donnelly P (2000) Inference of population structure
using multilocus genotype data. Genetics 155: 945–959.
14. Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-
Wheeler Transform. Bioinformatics 25: 1754–60.
15. Kurtz S, Phillippy A, Delcher AL, Smoot M, Shumway M, et al. (2004) Versatile
and open software for comparing large genomes. Genome Biology 5: R12.
16. Pearson T, Giffard P, Beckstrom-Sternberg S, Auerbach R, Hornstra H, et al.
(2009) Phylogeographic reconstruction of a bacterial species with high levels of
lateral gene transfer. BMC Biol 18: 78.
17. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5:
Molecular Evolutionary Genetics Analysis using Maximum Likelihood,
Evolutionary Distance, and Maximum Parsimony Methods. Molecular Biology
and Evolution. Mol Biol Evol. 2011 Aug 18. [Epub ahead of print].
18. Nei M, Kumar S (2000) Molecular Evolution and Phylogenetics. New York:
Oxford University Press. 132 p.
19. McCormick JB, Sexton DJ, McMurray JG, Carey E, Hayes P, et al. (1975)
Human-to-human transmission of Pseudomonas pseudomallei. Ann Intern Med
83(4): 512–3.
20. Holden MTG, Titball RW, Peacock SJ, Cerdeno-Tarraga AM, Crossman LC,
et al. (2004) Genomic plasticity of the causative agent of melioidosis,
Burkholderia pseudomallei. Proc Natl Acad Sci USA 101: 14240–14245.
21. Ulett GC, Currie BJ, Clair TW, Mayo M, Ketheesan N, et al. (2001)
Burkholderia pseudomallei virulence: definition, stability and association with
clonality. Microbes Infect 3(8): 621–31.
22. U’Ren JM, Schupp JM, Pearson T, Hornstra H, Friedman CL, et al. (2007)
Tandem repeat regions within the Burkholderia pseudomallei genome and their
application for high resolution genotyping. BMC Microbiol 30(7): 23.
23. Pearson T, U’Ren JM, Schupp JM, Allan GJ, Foster PG, et al. (2007) VNTR
analysis of selected outbreaks of Burkholderia pseudomallei in Australia. Infect
Genet Evol 7: 416–423.
24. Cheng AC, Ward L, Godoy D, Norton R, Mayo M, et al. (2008) Genetic
diversity of Burkholderia pseudomallei isolates in Australia. J Clin Microbiol
46(1): 249–254.
25. Currie BJ, Thomas AD, Godoy D, Dance DA, Cheng AC, et al. (2007)
Australian and Thai isolates of Burkholderia pseudomallei are distinct by
multilocus sequence typing: revision of a case of mistaken identity. J Clin
Microbiol 45(11): 3828–3829.
26. Pearson T, Okinaka RT, Foster JT, Keim P (2009) Phylogenetic understanding
of clonal populations in an era of whole genome sequencing. Infect Genet Evol
9: 1010–9.
27. Keim P, Van Ert MN, Pearson T, Vogler AJ, Huynh LY, et al. (2004) Anthrax
molecular epidemiology and forensics: using the appropriate marker for different
evolutionary scales. Infect Genet Evol 4: 205–13.
28. Engelthaler DM, Chiller T, Schupp JA, Colvin J, Beckstrom-Sternberg SM,
et al. (2011) Next-generation sequencing of Coccidioides immitis isolated during
cluster investigation. Emerg Infect Dis 17(2): 227–232.
29. Jeddeloh JA, Fritz DL, Waag DM, Hartings JM, Andrews GP (2003) Biodefense-
driven murine model of pneumonic melioidosis. Infect Immun 71(1): 584–7.
30. Ulett GC, Labrooy JT, Currie BJ, Barnes JL, Ketheesan N (2005) A model of
immunity to Burkholderia pseudomallei: unique responses following immuniza-
tion and acute lethal infection. Microbes Infect 7(11–12): 1263–75. Epub 2005
Jun 8.
31. Cummings CA, Bormann Chung CA, Fang R, Barker M, Brzoska PM, et al.
(2009) Whole-genome typing of Bacillus anthracis isolates by next-generation
sequencing accurately and rapidly identifies strain-specific diagnostic polymor-
phisms. Forensic Sci Int Genet 2: 300–301.
32. Harris SR, Feil EJ, Holden MT, Quail MA, Nickerson EK, et al. (2010)
Evolution of MRSA during hospital transmission and intercontinental spread.
Science 327(5964): 469–74.
33. Lienau EK, Strain E, Wang C, Zheng J, Ottesen AR, et al. (2011) Identification
of a Salmonellosis Outbreak by Means of Molecular Sequencing. N Engl J Med.
2011 Feb 23. 10.1056/NEJMc1100443 [Epub ahead of print].
Molecular Analysis of Non-Endemic Melioidosis Case
www.plosntds.org 6 October 2011 | Volume 5 | Issue 10 | e1347
